MedSci五周年---从Med-SCI到Medical Science

2012-08-21 MedSci MedSci原创

    临床研究 任重道远---从临床研究到学术论著 临床研究在中国有着巨大的机遇,因为中国有着大量的病例,病人招募的费用不到美国的1/3,中国目前是世界第3大药品市场,药品市场规模以每年15%的速度递增,个体化用药的趋势正在发展。我国最近几年临床研究有很大的进展,在不断创新与变化,但仍然存在诸多问题,比如临床研究水平不高,规

    临床研究 任重道远---从临床研究到学术论著

    临床研究在中国有着巨大的机遇,因为中国有着大量的病例,病人招募的费用不到美国的1/3,中国目前是世界第3大药品市场,药品市场规模以每年15%的速度递增,个体化用药的趋势正在发展。我国最近几年临床研究有很大的进展,在不断创新与变化,但仍然存在诸多问题,比如临床研究水平不高,规范性较差,创新性不足。基础与临床医学研究脱节,临床医务工作者缺乏从事医学科研的基本训练,没有形成一支强大和高水平的既懂基础又通临床的人才队伍。这些问题导致的直接结果是高质量学术论著产出不足。

    学术论著只是临床研究水到渠成的结果,而残缺的临床研究不可能产生高质量的学术论著,产出来自于投入,而投入只有从源头开始, 把关立意创新性,研究规范性,有了高质量的临床研究,才会有高质量的学术论著。

    助力医学 科学服务---从Med-SCI到Medical Science

    在这里有全球著名高校的众多医药、生物专业博士团队---MedSci已服务几十个细分学科的众多客户,包括临床医生,科研人员和多家跨国医药企业。

    在这里有“MedSci临床科研中国行”公益讲座---MedSci深入高校,科研院所,SCI期刊编辑部与各三甲医院及科室,认真分享,收集意见,及时反馈,从最开始的“SCI论文写作与发表”单一主题优化提炼到“学术论著发表,高级医学统计,循证医学,NSFC”四大主题,有讲者的辛勤付出,更有听者的真诚反馈。

    在这里有“MedSci高质量临床研究之路”---在北京站巡回MedSci来到中国人民解放军第三0一医院,北京天坛医院和北京儿童医院,带来了《高质量临床研究之路》和《医学论著结构化写作与发表》的精彩讲座。从临床试验设计到医学研究伦理,从写作到发表技巧,讲者娓娓道来,听者受益良多。

    在这里有www.medsci.cn ---网站每天超过25000位用户访问,有SCI期刊的影响因子及文献,15000份SCI投稿经验点评,实时期刊热点解读,智能投稿选择辅助系统JSAS,大量医药科研动态。轻点鼠标,了解最新SCI期刊影响因子和投稿经验;足不出户,知晓国内外重大医学资讯。

    感谢有你 真情回馈---从“三重好礼”到“参会名额获赠”

    MedSci的成长离不开广大客户的支持,为感谢广大客户,MedSci在五周年庆来临之际开展超值回馈活动,希望下一个五年我们共同发展和壮大。

    活动时间:2012年8月27日-8月31日(周一~周五)

    活动内容:专业中译英服务

    具体活动内容请点击:MedSci五周年庆 超值回馈

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1858563, encodeId=4eab18585636a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Mar 17 12:32:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374667, encodeId=a19d13e46670c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533539, encodeId=2e9515335393c, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605823, encodeId=8d111605823cb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=)]
    2013-03-17 jeanqiuqiu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1858563, encodeId=4eab18585636a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Mar 17 12:32:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374667, encodeId=a19d13e46670c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533539, encodeId=2e9515335393c, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605823, encodeId=8d111605823cb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=)]
    2012-08-23 jichang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1858563, encodeId=4eab18585636a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Mar 17 12:32:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374667, encodeId=a19d13e46670c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533539, encodeId=2e9515335393c, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605823, encodeId=8d111605823cb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=)]
    2012-08-23 海豹
  4. [GetPortalCommentsPageByObjectIdResponse(id=1858563, encodeId=4eab18585636a, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sun Mar 17 12:32:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374667, encodeId=a19d13e46670c, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533539, encodeId=2e9515335393c, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605823, encodeId=8d111605823cb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 23 08:32:00 CST 2012, time=2012-08-23, status=1, ipAttribution=)]